Centre for Addiction and Mental Health

- Country
- 🇨🇦Canada
- Ownership
- -
- Established
- 1998-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
331
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (310 trials with phase data)• Click on a phase to view related trials
Do Antipsychotics Block Insulin Action in the Brain: is it a Class Effect?
- Conditions
- Brain Insulin SensitivityHealthy ControlsCognition
- Interventions
- First Posted Date
- 2025-08-07
- Last Posted Date
- 2025-08-07
- Lead Sponsor
- Centre for Addiction and Mental Health
- Target Recruit Count
- 35
- Registration Number
- NCT07109245
- Locations
- 🇨🇦
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
THC Titration of High-Potency Cannabis Concentrates
- Conditions
- THC
- Interventions
- Drug: Cannabis (30% THC Concentrate)Drug: Cannabis (60% THC Concentrate)Drug: Cannabis (90% THC Concentrate)
- First Posted Date
- 2025-08-06
- Last Posted Date
- 2025-08-06
- Lead Sponsor
- Centre for Addiction and Mental Health
- Target Recruit Count
- 48
- Registration Number
- NCT07105449
- Locations
- 🇨🇦
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Theta-Burst Stimulation to Treat Depression
- Conditions
- Major Depressive Disorder (MDD)
- First Posted Date
- 2025-06-24
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- Centre for Addiction and Mental Health
- Target Recruit Count
- 84
- Registration Number
- NCT07033780
- Locations
- 🇨🇦
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
Talking for Change: Secondary Prevention of Child Sexual Abuse Perpetration
- Conditions
- PedophiliaHebephiliaChild Sexual AbuseProgram EvaluationPrevention InterventionParaphilias and Paraphilic Disorders
- First Posted Date
- 2025-06-03
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- Centre for Addiction and Mental Health
- Target Recruit Count
- 220
- Registration Number
- NCT07001735
- Locations
- 🇨🇦
Centre for Addiction and Mental Health, Toronto, Ontario, Canada
HABITS Study (Helping Addiction by Individualized Therapeutic Stimulation): Pilot Trial of Deep Brain Stimulation Guided By Stereoelectroencephalography for Treatment-Refractory Substance Use Disorders
- Conditions
- AddictionSubstance Use Disorder (SUD)
- First Posted Date
- 2025-05-15
- Last Posted Date
- 2025-05-25
- Lead Sponsor
- Centre for Addiction and Mental Health
- Target Recruit Count
- 10
- Registration Number
- NCT06973512
- Locations
- 🇨🇦
Centre for Addiction and Mental Health / Toronto Western Hospital, Toronto, Ontario, Canada
- Prev
- 1
- 2
- 3
- 4
- 5
- 66
- Next
News
Viatris Launches First Clozapine Orally Disintegrating Tablet in Canada for Treatment-Resistant Schizophrenia
Viatris has launched Gen-Clozapine orally disintegrating tablets in Canada, marking the first availability of this formulation for treatment-resistant schizophrenia patients.